课题基金 / 基金详情

Recognition and Validation of Druggable Targets from the Response to Cognitive Behaviour Therapy in Myotonic Dystrophy type 1 patients from Integrated -Omics Networks

Recognition and Validation of Druggable Targets from the Response to Cognitive Behaviour Therapy in Myotonic Dystrophy type 1 patients from Integrated -Omics Networks
来自 Integrated-Omics Networks 的强直性肌营养不良 1 型患者对认知行为治疗反应的可药物靶标的识别和验证
批准号：
387442
负责人：
Mackenzie Alexander E
金额：
$5.46万
依托单位：
University of Ottawa
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2018
资助国家：
加拿大
项目状态：
已结题
起止时间：
2018-06-01 至 2021-06-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=387442&lang=en
关键词：
Cognitive Behavioural Therapy (Cbt) Myotonic Dystrophy Type 1 (Dm1) Systems Biology

项目摘要

项目成果

Mackenzie Alexander E的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Myotonic dystrophy type 1 (DM1) is the most common adult form of muscular dystrophy affects virtually all tissues; the untreatable condition causes significant illness and death impacting patient and family quality of life and socio-economic status. Lim
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pharmacologic and RNAi Screens for Myotonic Dystrophy Type 1 foci modulators; towards Novel DM1 therapeutic approaches
Preclinical assessment of clinic ready agents for the treatment of muscular dystrophy and spinal muscular atrophy
海外基金